Daclatasvir/asunaprevir based direct-acting antiviral therapy ameliorate hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis: a case report

BACKGROUND: Direct-acting antivirals (DAAs) dramatically improve the treatment of hepatitis C virus (HCV) infections. However, the effects of DAAs on extra-hepatic manifestations such as HCV-associated glomerulonephritis, especially in cases with renal dysfunction, are not well elucidated. CASE PRES...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimada, Michiko, Nakamura, Norio, Endo, Tetsu, Yamabe, Hideaki, Nakamura, Masayuki, Murakami, Reiichi, Narita, Ikuyo, Tomita, Hirofumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372252/
https://www.ncbi.nlm.nih.gov/pubmed/28356063
http://dx.doi.org/10.1186/s12882-017-0534-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372252/
https://www.ncbi.nlm.nih.gov/pubmed/28356063
http://dx.doi.org/10.1186/s12882-017-0534-5

Ejemplares similares